Concepedia

Charles W. Bishop

CW

Statistics

Publications

45

Citations

2.2K

H-Index

28

Active since

1951

Affiliations

University at Buffalo, State University of New York(Current)

Buffalo General Medical Center

Queen's University

OPKO Health (United States)

West Los Angeles College

Charles W. Bishop is an author at University at Buffalo, State University of New York specializing in medicine, physiology, and pharmacology.

ORCID

Top concepts

Publications per year

1951–2023

45

Publications

45

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4

Jack W. Coburn, Hla M. Maung, Logan Elangovan et al. · American Journal of Kidney Diseases · 2004 · 172 citations

, , +7

Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

Alexander U. Tan, Barton S. Levine, Richard B. Mazess et al. · Kidney International · 1997 · 138 citations · Full text

, , +8

The Nucleotides in Normal Human Blood

Charles W. Bishop, David M. Rankine, John H. Talbott · Journal of Biological Chemistry · 1959 · 135 citations · Full text

, , +9

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism

João Frazão, Loganathan Elangovan, Hla M. Maung et al. · American Journal of Kidney Diseases · 2000 · 129 citations

, , +5

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.

Hla M. Maung, L Elangovan, João Frazão et al. · PubMed · 2001 · 110 citations

1–5 of 45